Skip to Content

UK Edition. Click here for US version.

CO-CODAMOL 30/500MG TABLETS BP

Active substance(s): CODEINE PHOSPHATE / PARACETAMOL / CODEINE PHOSPHATE / PARACETAMOL / CODEINE PHOSPHATE / PARACETAMOL

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

02090160R02090160L00-M050UMAPB

HEAD

VERSION
Customer
Description

M&A Pharmachem
CO-CODAMOL 30/500MG
TABLETS

Drawing

L00000446

Flat Size

209.55 x 160

mm

Fold Size/Lip

209.55 x 160

mm / 0

Item Code

PP2476

Material

PPN/2nd Code

163823

Pharmacode/
2D Code

242

Type/Pages

Reel

Operator

Yarnold, Paul

View/Backup

050 gsm Uncoated

1110011
2 pp

Colours
FRONT
(or cover)
Colours
BACK
(or inner)
History

Title

D

HEAD to HEAD

Black

Black

D on 16/11/2016 09:03:58

Submitted

Attention: The colours displayed in this proof are for electronic representational purposes only. Please refer to the PANTONE® colour guides for accurate colour matching. By approving this file, you are signifying full approval of design and text. To ensure
accurate viewing and printing of this PDF file, Overprint Preview must be activated for accurate colour representation. MPS Leaflets PDF files are designed to work with Adobe Acrobat 6 or higher and are PDF/X-01a-2001 compliant.

02090160R02090160L00-M050UMAPB

HEAD

‡ Very rare cases of serious skin reactions have been reported.
‡ Serious, sudden allergic reaction with symptoms such as fever and

blisters on the skin and peeling of the skin (toxic epidermal necrolysis).

‡ A serious blistering condition of the skin, mouth, eyes and genitals
(Stevens-Johnson syndrome).

Adults, and the Elderly: Take one or two tablets every 4-6 hours. Do not
take more than 8 tablets in any 24 hour period.
A lower dosage may be needed if you are elderly or have other medical
problems. Check with your doctor about this.
Children aged 16-18 years: Take one or two tablets every 6 hours when
required. Do not take more than 8 tablets in any 24 hour period.
Children aged 12-15 years: Take one tablet every 6 hours when required.
Do not take more than 4 tablets in any 24 hour period.
Children aged less than 12 years: Co-codamol tablets should not be used
in children under the age of 12 years, due to the risk of severe breathing
problems.
DO NOT EXCEED THE STATED DOSE

‡ blood disorders such as thrombocytopenia (reduction in blood platelets,
which increases risk of bleeding or bruising), neutropenia and
leucopenia (reduction in white blood cells, which may make infection
more likely) and pancytopenia (severe reduction in blood cells which
can cause weakness, bruising or make infections more likely)

November 2016

PP2476

VERSION
Customer
Description

M&A Pharmachem
CO-CODAMOL 30/500MG
TABLETS

Drawing

L00000446

Flat Size

209.55 x 160

mm

Fold Size/Lip

209.55 x 160

mm / 0

Item Code

PP2476

Material

PPN/2nd Code

163823

Pharmacode/
2D Code

242

Type/Pages

Reel

Operator

Yarnold, Paul

View/Backup

050 gsm Uncoated

1110011
2 pp

Colours
FRONT
(or cover)
Colours
BACK
(or inner)
History

Title

D

HEAD to HEAD

Black

Black

D on 16/11/2016 09:03:58

Submitted

Attention: The colours displayed in this proof are for electronic representational purposes only. Please refer to the PANTONE® colour guides for accurate colour matching. By approving this file, you are signifying full approval of design and text. To ensure
accurate viewing and printing of this PDF file, Overprint Preview must be activated for accurate colour representation. MPS Leaflets PDF files are designed to work with Adobe Acrobat 6 or higher and are PDF/X-01a-2001 compliant.

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide